Literature DB >> 24446175

The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease.

Ruey-Meei Wu1, Chin-Hsien Lin, Han-I Lin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24446175     DOI： 10.1212/WNL.0000000000000004

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

1.  Systematic Genetic Analysis of the SMPD1 Gene in Chinese Patients with Parkinson's Disease.

Authors:  Sheng Deng; Xiong Deng; Zhi Song; Xiaofei Xiu; Yi Guo; Jingjing Xiao; Hao Deng
Journal:  Mol Neurobiol       Date:  2015-09-16       Impact factor: 5.590

2.  Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.

Authors:  Laurie A Robak; Iris E Jansen; Jeroen van Rooij; André G Uitterlinden; Robert Kraaij; Joseph Jankovic; Peter Heutink; Joshua M Shulman
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

Review 3.  Genetic convergence of Parkinson's disease and lysosomal storage disorders.

Authors:  Hao Deng; Xiaofei Xiu; Joseph Jankovic
Journal:  Mol Neurobiol       Date:  2014-08-07       Impact factor: 5.590

4.  Association study between SMPD1 p.L302P and sporadic Parkinson's disease in ethnic Chinese population.

Authors:  Kai Li; Bei-Sha Tang; Nan-Nan Yang; Ji-Feng Kang; Zhen-Hua Liu; Rui-Qi Liu; Xin-Xiang Yan; Lu Shen; Ji-Feng Guo
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 5.  Therapeutic potential of autophagy-enhancing agents in Parkinson's disease.

Authors:  Tim E Moors; Jeroen J M Hoozemans; Angela Ingrassia; Tommaso Beccari; Lucilla Parnetti; Marie-Christine Chartier-Harlin; Wilma D J van de Berg
Journal:  Mol Neurodegener       Date:  2017-01-25       Impact factor: 14.195

Review 6.  Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's Disease.

Authors:  Silvia Paciotti; Elisabetta Albi; Lucilla Parnetti; Tommaso Beccari
Journal:  J Clin Med       Date:  2020-02-21       Impact factor: 4.241

7.  Chronic Cerebral Hypoperfusion Aggravates Parkinson's Disease Dementia-Like Symptoms and Pathology in 6-OHDA-Lesioned Rat through Interfering with Sphingolipid Metabolism.

Authors:  Yaohua Fan; Mengzhu Li; Chunxiao Wu; Yubiao Wu; Jiajun Han; Peipei Wu; Zifeng Huang; Qizhang Wang; Lijun Zhao; Dongfeng Chen; Meiling Zhu
Journal:  Oxid Med Cell Longev       Date:  2022-08-08       Impact factor: 7.310

Review 8.  Genetic perspective on the synergistic connection between vesicular transport, lysosomal and mitochondrial pathways associated with Parkinson's disease pathogenesis.

Authors:  Stefanie Smolders; Christine Van Broeckhoven
Journal:  Acta Neuropathol Commun       Date:  2020-05-06       Impact factor: 7.801
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.